ELVA.TOELVA.TOTSX
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank59
3Y CAGR-13.3%
5Y CAGR-41.3%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-13.3%/yr
vs -42.7%/yr prior
5Y CAGR
-41.3%/yr
Recent acceleration
Acceleration
+29.4pp
Accelerating
Percentile
P59
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 7.51% |
| Q3 2025 | -1.11% |
| Q2 2025 | 9.25% |
| Q1 2025 | 8.74% |
| Q4 2024 | 149.11% |
| Q3 2024 | -61.91% |
| Q2 2024 | 61.53% |
| Q1 2024 | -33.40% |
| Q4 2023 | 36.35% |
| Q3 2023 | 3.21% |
| Q2 2023 | -22.77% |
| Q1 2023 | -19.58% |
| Q4 2022 | 11.53% |
| Q3 2022 | 4.77% |
| Q2 2022 | -19.93% |
| Q1 2022 | 49.81% |
| Q4 2021 | -52.04% |
| Q3 2021 | 62.96% |
| Q2 2021 | 0.60% |
| Q1 2021 | 10.49% |
| Q4 2020 | 107.32% |
| Q3 2020 | -49.19% |
| Q2 2020 | -17.94% |
| Q1 2020 | 159.41% |
| Q4 2019 | -39.43% |
| Q3 2019 | 70.59% |
| Q2 2019 | -55.47% |
| Q1 2019 | -5.29% |
| Q4 2018 | -22.88% |
| Q3 2018 | 36.59% |
| Q2 2018 | -14.06% |
| Q1 2018 | 42.42% |
| Q4 2017 | -41.11% |
| Q3 2017 | -27.15% |
| Q2 2017 | -8.86% |
| Q1 2017 | 40.70% |
| Q4 2016 | -22.53% |
| Q3 2016 | -7.51% |
| Q2 2016 | 0.39% |
| Q1 2016 | 121.86% |